Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Wellmarker Bio

Wellmarker Bio

Wellmarker Bio, the company that specializes in first-in-class anticancer drug development was introduced as an innovative growth company in The Korea Economic Daily's TV program on November 28, 2020. With the hope to provide an appropriate drug to patients, Wellmarker Bio is developing anticancer drugs and predictive biomarkers based on the patient's unmet medical needs and is growing at a fast pace.

Last updated on

About Wellmarker Bio

Founded

2016

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$43M

Category

Industry

Biotechnology

Location

City

Seoul

State

Seoul

Country

South Korea
Wellmarker Bio

Wellmarker Bio

Find your buyer within Wellmarker Bio

Tech Stack (0)

search